4D Molecular Therapeutics Inc.

2 Day Stock Trading Bootcamp
Join Tim Sykes and other millionaire traders at this exclusive stock trading bootcamp
Save your seat Analyst Ratings
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
4D Molecular Therapeutics Inc. Earnings
We don't currently have information about 4D Molecular Therapeutics Inc.'s earnings.